ARS Pharmaceuticals, Inc. SPRY Inventory Current
Inventory Current at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept spry:InventoryCurrent.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s inventory current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s inventory current?
- ARS Pharmaceuticals, Inc. (SPRY) reported inventory current of $8.82M in Q1 2026.
- What does inventory current mean?
- This metric represents the aggregate value of raw materials, work-in-progress, and finished pharmaceutical products held by the company. It serves as a critical indicator of supply chain readiness and the company's ability to meet market demand for its therapeutic products. Monitoring this balance helps assess potential obsolescence risks and the efficiency of inventory turnover cycles.